The Mechanism of High-Level Carbapenem Resistance in Klebsiella pneumoniae : Underlying Ompk36-Deficient Strains Represent a Threat of Emerging High-Level Carbapenem-Resistant K. pneumoniae with IMP-1 β-Lactamase Production in Japan
Authors:
- 1 August 2013
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 19 (4) , 274-281
Abstract
The mechanisms of high-level carbapenem resistance in Klebsiella pneumoniae isolated in Japan were investigated. High-level carbapenem-resistant K. pneumoniae Mkp4437 and a less carbapenem-sensitive K. pneumoniae strain, Mkp4365, were recovered from the same patient. These two strains were found to be homologous by pulsed-field gel electrophoresis, and both strains contained bla IMP-1 , bla DHA-1 , bla CTXM-14 , bla TEM-1 , and bla SHV-1 . Based on the sodium dodecyl sulfate–polyacrylamide gel electrophoresis analysis, the lack of Ompk36 was observed in Mkp4437. Direct sequencing of the ompK36 gene demonstrated that a new insertional sequence in the open reading frame of the ompK36 gene was found in Mkp4437. Three clinical isolates (minimum inhibitory concentration [MIC] 2–4 mg/L to imipenem) were identified upon screening the strains of K. pneumoniae isolated in the University hospital with MICs of ≥1 mg/L to imipenem. Interestingly, these three isolates all lacked OmpK36. Conjugation of the plasmid harboring IMP-1 to these three OmpK36-deficient strains led to the isolation of high-level carbapenem-resistant transconjugants. In conclusion, the mechanisms of high-level carbapenem resistance in K. pneumoniae entail not only the production of IMP-1 β-lactamase but also the lack of OmpK36. It is vital to monitor for the presence of less carbapenem-sensitive K. pneumoniae strains, which lack OmpK36, because bla IMP-1 transmission to these strains may result in isolates with a high-level carbapenem-resistant phenotype.Keywords
This publication has 39 references indexed in Scilit:
- Carbapenem resistance in Enterobacteriaceae: here is the storm!Trends in Molecular Medicine, 2012
- First Outbreak of a Plasmid-Mediated Carbapenem-Hydrolyzing OXA-48 β-Lactamase in Klebsiella pneumoniae in SpainAntimicrobial Agents and Chemotherapy, 2011
- NDM-1 — A Cause for Worldwide ConcernNew England Journal of Medicine, 2010
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in GermanyEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- An Outbreak of Infection due to β‐LactamaseKlebsiella pneumoniaeCarbapenemase 2–ProducingK. pneumoniaein a Greek University Hospital: Molecular Characterization, Epidemiology, and OutcomesClinical Infectious Diseases, 2010
- Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)Journal of Infection, 2009
- Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli HospitalAntimicrobial Agents and Chemotherapy, 2007
- Carbapenemases: the Versatile β-LactamasesClinical Microbiology Reviews, 2007
- High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of bla ACT-1 β-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoEAntimicrobial Agents and Chemotherapy, 2006